FDA Reverses Black Box Warning on Female HRT

In this episode, Rejuvime provider Ebony and our hosts break down the FDA’s historic reversal of the long-standing “black box” warning on female hormone replacement therapy. We explore what this decision means for women’s health, how it impacts HRT safety perceptions, and what patients should know moving forward. Thanks for watching and be sure to follow for new episodes every Tuesday!